These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30173222)

  • 1. Gender and Mortality after Radical Cystectomy: Competing Risk Analysis.
    Heberling U; Koch R; Hübler M; Baretton GB; Hakenberg OW; Wirth MP; Froehner M
    Urol Int; 2018; 101(3):293-299. PubMed ID: 30173222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy.
    Froehner M; Muallah D; Koch R; Hübler M; Borkowetz A; Heberling U; Huber J; Wirth MP; Thomas C
    Urol Int; 2020; 104(1-2):62-69. PubMed ID: 31639810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy.
    Froehner M; Koch R; Heberling U; Novotny V; Hübler M; Wirth MP
    Urol Oncol; 2017 Jan; 35(1):32.e17-32.e23. PubMed ID: 27519277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis.
    Froehner M; Koch R; Heberling U; Novotny V; Oehlschlaeger S; Hübler M; Baretton GB; Hakenberg OW; Wirth MP
    Eur Urol; 2016 Jun; 69(6):984-7. PubMed ID: 26194042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection Effects May Explain Smoking-related Outcome Differences After Radical Cystectomy.
    Froehner M; Koch R; Hübler M; Heberling U; Novotny V; Zastrow S; Baretton GB; Wirth MP
    Eur Urol Focus; 2018 Apr; 4(3):395-398. PubMed ID: 28753798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
    Rosenblatt R; Sherif A; Rintala E; Wahlqvist R; Ullén A; Nilsson S; Malmström PU;
    Eur Urol; 2012 Jun; 61(6):1229-38. PubMed ID: 22189383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Shimizu F; Muto S; Taguri M; Ieda T; Tsujimura A; Sakamoto Y; Fujita K; Okegawa T; Yamaguchi R; Horie S
    Int J Urol; 2017 May; 24(5):367-372. PubMed ID: 28281310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy.
    Froehner M; Koch R; Hübler M; Heberling U; Novotny V; Zastrow S; Hakenberg OW; Wirth MP
    BMC Urol; 2018 Oct; 18(1):91. PubMed ID: 30348141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis.
    Messer JC; Shariat SF; Dinney CP; Novara G; Fradet Y; Kassouf W; Karakiewicz PI; Fritsche HM; Izawa JI; Lotan Y; Skinner EC; Tilki D; Ficarra V; Volkmer BG; Isbarn H; Wei C; Lerner SP; Curiel TJ; Kamat AM; Svatek RS
    Urology; 2014 Apr; 83(4):863-7. PubMed ID: 24485993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomy.
    Froehner M; Novotny V; Heberling U; Rutsch L; Litz RJ; Hübler M; Koch R; Baretton GB; Wirth MP
    Eur Urol; 2014 Dec; 66(6):987-90. PubMed ID: 25150172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
    BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
    Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy.
    Zareba P; Patterson L; Pandya R; Margel D; Hotte SJ; Mukherjee SD; Elavathil L; Daya D; Shayegan B; Pinthus JH
    Urol Oncol; 2014 Oct; 32(7):975-80. PubMed ID: 25027682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.
    Soave A; Dahlem R; Hansen J; Weisbach L; Minner S; Engel O; Kluth LA; Chun FK; Shariat SF; Fisch M; Rink M
    Eur J Surg Oncol; 2015 Mar; 41(3):368-77. PubMed ID: 24674298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study.
    Leveridge MJ; Siemens DR; Mackillop WJ; Peng Y; Tannock IF; Berman DM; Booth CM
    Urology; 2015 Apr; 85(4):791-8. PubMed ID: 25661830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.